explore -WSS

explore

author：Wikipedia 2025-09-29 22:36:34 - browse：17599

Dallas Mavericks owner Mark Cuban reacts during a timeout in the game against the Golden State Warriors at American Airlines Center on March 22, 2023 in Dallas, Texas. – opinion coverage from STAT — Tim Heitman/Getty Images

Mark Cuban, the Dallas Mavericks owner and “Shark Tank” star, has been making headlines recently with his direct-to-consumer venture, Cost Plus Drugs. The company sells generic prescription drugs and boasts more than 2 million members. As a family medicine specialist who has firsthand experience with American households’ dissatisfaction with the state of the nation’s prescription drug marketplace, I believe the enthusiasm for Cost Plus Drugs reveals an appetite for alternatives to the status quo in the pharmaceutical industry.

Cuban claims the reason behind the success of Cost Plus Drugs is the company’s decision to bypass pharmaceutical benefit managers — the negotiating agents insurance companies hire to negotiate big pharma’s prices down. But that might not be the case. Instead, its success appears to lie in its choice to collaborate with affordable generic drug manufacturers rather than the major pharmaceutical companies.

Last year, the Department of Health and Human Services found that between July 2021 and July 2022, major pharma companies raised the list price on more than 1,200 drugs by an average of 31 percent. That’s 23 percent more than the country’s overall inflation rate during the same period. Meanwhile, generic drug companies saved the U.S. roughly $2.6 trillion from 2012 to 2021, according to the Association for Accessible Medicines, a trade group representing generic drug manufacturers.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： Canadians with cystic fibrosis outlive Americans by a decade

explore

WSS

Faced with fears of OxyContin misuse, sales reps touted its safety

A letter from the executive editor: The 2023 STATUS List

Crowdfunding for unproven stem cell procedures spreads misinformation

O'Shea Sibley was killed after expressing queer joy by voguing, activists say

Top Ukrainian generals say counteroffensive is 'going to plan' as losses mount

House GOP releases memo on Hunter Biden foreign business dealings, reviving old claims

explore

explore

focus

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

O'Shea Sibley was killed after expressing queer joy by voguing, activists say

In age of alternative facts, a scholarly course on calling out crap

Canadians with cystic fibrosis outlive Americans by a decade

Wildfire smoke exposes gaps in outdoor worker protections

An innovative path out of biotech’s “valley of death”

Wildfire smoke exposes gaps in outdoor worker protections

Being 'nonadherent' patient made me a more empathetic doctor

Cancer drug shortages should be causing more outrage

O'Shea Sibley was killed after expressing queer joy by voguing, activists say

focus

After John Oliver segment, STAT readers share their opioid

Pharma budget tightening trickles down to Doximity

Hubble vs. James Webb telescope images: See the difference

Fatty liver disease was alleviated by Lilly’s ‘triple

A letter from the executive editor: The 2023 STATUS List

Canadians with cystic fibrosis outlive Americans by a decade

entertainment

explore

explore

focus